Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

2.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

Church DA, Kanga JF, Kuhn RJ, Rubio TT, Spohn WA, Stevens JC, Painter BG, Thurberg BE, Haverstock DC, Perroncel RY, Echols RM.

Pediatr Infect Dis J. 1997 Jan;16(1):97-105; discussion 123-6.

PMID:
9002118
3.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smyth AR.

Cochrane Database Syst Rev. 2014 Nov 10;(11):CD004197. doi: 10.1002/14651858.CD004197.pub4. Review.

PMID:
25383937
5.

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.

Clin Microbiol Infect. 2005 Sep;11(9):690-703. Review.

6.

Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.

Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, Ramsey BW; Early Pseudomonas Infection Control (EPIC) Investigators.

Arch Pediatr Adolesc Med. 2011 Sep;165(9):847-56. doi: 10.1001/archpediatrics.2011.136.

7.

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.

Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B.

Pediatr Infect Dis J. 1997 Jan;16(1):106-11; discussion 123-6.

PMID:
9002119
8.
9.

Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.

Treggiari MM, Rosenfeld M, Mayer-Hamblett N, Retsch-Bogart G, Gibson RL, Williams J, Emerson J, Kronmal RA, Ramsey BW; EPIC Study Group.

Contemp Clin Trials. 2009 May;30(3):256-68. doi: 10.1016/j.cct.2009.01.003. Epub 2009 Jan 15.

10.

Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.

Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.

Pediatr Pulmonol. 2001 May;31(5):367-76.

PMID:
11340683
11.

Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.

Vic P, Ategbo S, Turck D, Husson MO, Launay V, Loeuille GA, Sardet A, Deschildre A, Druon D, Arrouet-Lagande C.

Arch Dis Child. 1998 Jun;78(6):536-9.

12.

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis.

Gold R, Overmeyer A, Knie B, Fleming PC, Levison H.

Pediatr Infect Dis. 1985 Mar-Apr;4(2):172-7.

PMID:
3885181
13.

Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Stenvang Pedersen S, Pressler T, Pedersen M, Høiby N, Friis-Møller A, Koch C.

Scand J Infect Dis. 1986;18(2):133-7.

PMID:
3518048
14.

Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis.

Adeboyeku D, Jones AL, Hodson ME.

J Cyst Fibros. 2011 Jan;10(1):25-30. doi: 10.1016/j.jcf.2010.09.003.

15.
17.

[Tolerance and efficacy of ceftazidime in combination with aztreonam for exacerbations of cystic fibrosis].

Prévotat A, Leroy S, Perez T, Wallet F, Wallaert B.

Rev Mal Respir. 2010 May;27(5):449-56. doi: 10.1016/j.rmr.2010.03.015. Epub 2010 Apr 28. French.

PMID:
20569877
18.

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.

Smyth A, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D, Prof Knox A; TOPIC Study Group.

Lancet. 2005 Feb 12-18;365(9459):573-8.

PMID:
15708100
19.
20.

Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R.

Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):858-65.

PMID:
2512129

Supplemental Content

Support Center